Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T09:22:36.289Z Has data issue: false hasContentIssue false
  • English
  • Français

The place of beta-adrenoreceptor-blocking drugs in the treatment of congestive heart failure in elderly people: review of current opinion

Part of: Bespoke shallow archive Weizmann

Published online by Cambridge University Press:  01 February 1998

L Woosnam  and
M Hasan
L Woosnam
Affiliation:
Caerphilly District Miners‘ Hospital, Caerphilly, South Wales, and University of Wales College of Medicine, Cardiff, UK
M Hasan
Affiliation:
Caerphilly District Miners‘ Hospital, Caerphilly, South Wales, and University of Wales College of Medicine, Cardiff, UK
Get access Rights & Permissions [Opens in a new window]

Abstract

The clinical syndrome of heart failure affects more than 1% of the population, and its prevalence increases steeply with advancing age, especially after 75, where it reaches approximately 10%. It is one of the commonest reasons for the admission of elderly people to hospital.

Despite recent advances in treatment of heart failure with angiotensin-converting enzyme (ACE) inhibitors, which were proven to provide survival benefit, the rates of morbidity and mortality from heart failure remain high, and new therapeutic strategie s are needed.

Type
Review Article
Information
Reviews in Clinical Gerontology , Volume 8 , Issue 1 , February 1998 , pp. 89 - 92
Copyright
© Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)